Insider Ledger

HELP insider buying and SEC filings, explained

Helus Pharma Inc. · CIK 1833141

Tracked: Forms 3/4/5, 8-K, NT · Limited coverage: files 6-K/20-F, not covered in v1 · All filings on sec.gov

Company profile

Exchanges
Nasdaq
Industry (SIC)
Pharmaceutical Preparations
State of incorporation
A1
Fiscal year end
Mar 31
Former names
CYBIN INC.

Insider activity in the last 12 months

Bought
$9.7M
Insiders who bought
4
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0

Insider purchases and sales, last 12 months

TradedTypeWhat was filedSource
Sep 29, 2026Purchase (code P)Greg Cavers (CFO) bought 3,000 shares indirectly (by spouse) at $12.91 ($39K), reported as a purchase (code P). New position of 3,000 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Oct 1, 2026, 8:13 PM ET
Sep 21, 2026Purchase (code P)Michael Halstead (CEO) bought 100,000 shares at about $13.47 ($1.3M), reported as a purchase (code P). Holdings up 146% to 168,568 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Sep 21, 2026
Sep 8, 2026Purchase (code P)Paul Glavine (Chief Growth Officer) bought 100,000 shares at $12.47 ($1.2M), reported as a purchase (code P). Holdings up 2% to 4,271,252 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Sep 11, 2026
Sep 8, 2026Purchase (code P)Paul Glavine (Chief Growth Officer) bought 100,000 shares at $12.47 ($1.2M), reported as a purchase (code P). Holdings up 2% to 4,271,252 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Sep 11, 2026
Sep 8, 2026Purchase (code P)Eric H. L. So (Chair and Director) bought 100,000 shares at $12.39 ($1.2M), reported as a purchase (code P). Holdings up 2% to 4,465,014 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Sep 11, 2026
Sep 4, 2026Purchase (code P)Eric H. L. So (Chair and Director) bought 100,000 shares at $12.09 ($1.2M), reported as a purchase (code P). Holdings up 2% to 4,365,014 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Sep 10, 2026
Sep 3, 2026Purchase (code P)Paul Glavine (Chief Growth Officer) bought 100,000 shares at $11.78 ($1.2M), reported as a purchase (code P). Holdings up 2% to 4,171,252 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Sep 10, 2026
Sep 1, 2026Purchase (code P)Eric H. L. So (Chair and Director) bought 95,000 shares at $11.81 ($1.1M), reported as a purchase (code P). Holdings up 2% to 4,265,014 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Sep 9, 2026
Aug 31, 2026Purchase (code P)Paul Glavine (Chief Growth Officer) bought 90,000 shares at $11.59 ($1.0M), reported as a purchase (code P). Holdings up 2% to 4,071,252 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Sep 9, 2026

2 routine transactions (such as grants, option exercises or tax withholding) are not listed.

Cluster buys

4 insiders bought in 30 days

$9.7M in purchases since Aug 31, 2026 · Purchases traded Aug 31, 2026 to Sep 29, 2026 · Closed

InsiderValueTradedSource
Paul Glavine (Chief Growth Officer)$1.0MAug 31, 2026SEC filing
Eric H. L. So (Chair)$1.1MSep 1, 2026SEC filing
Paul Glavine (Chief Growth Officer)$1.2MSep 3, 2026SEC filing
Eric H. L. So (Chair)$1.2MSep 4, 2026SEC filing
Eric H. L. So (Chair)$1.2MSep 8, 2026SEC filing
Paul Glavine (Chief Growth Officer)$1.2MSep 8, 2026SEC filing
Paul Glavine (Chief Growth Officer)$1.2MSep 8, 2026SEC filing
Michael Halstead (CEO)$1.3MSep 21, 2026SEC filing
Greg Cavers (CFO)$39KSep 29, 2026SEC filing

Red flags

No red flags in the last 12 months.

Key events

No key events in the last 12 months.

8-K filings, last 12 months

No 8-K filings in the last 12 months.

Red flags are objective triggers only: the item or form filed, never an opinion.

Follow HELP in the Insider Ledger app

A plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.

Get the app